神经瘤学中的aptamers:一种新兴的治疗方式
Caroline Doherty1,2, Brandon Wilbanks3,4, Soumen Khatua5
1Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.
Neuro-oncology
|August 24, 2023
概括
亚胺是DNA或RNA分子,通过克服传统治疗挑战,显示出治疗脑瘤的前景. 这些分子提供了潜在的优势,比如穿越血脑屏障,用于创新的神经瘤治疗.
科学领域:
- 生物技术是生物技术.
- 神经瘤学神经瘤学
- 分子生物学分子生物学
背景情况:
- 脑瘤治疗由于瘤的位置和特征而面临挑战.
- 体是DNA/RNA分子,对标具有高度亲和力和特异性,类似于抗体.
- 阿普塔默技术为神经瘤治疗提供了一种新的方法.
研究的目的:
- 审查近期在神经瘤学中应用的阿巴美尔.
- 突出阿普塔默在克服传统治疗局限性的优势.
- 确定以aptamer为基础的神经瘤学工具的临床翻译的未来方向.
主要方法:
- 对神经瘤学中aptamer应用的临床前研究的审查.
- 通过细胞和体内体内的细胞和体内体内的体内体内的体内体内的体内体内的体内体内的体内体内的体内体内的体内体内的体内体内的体内体内的体内体内的体内体内的体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内体内
- 针对阿普坦的治疗输送,诊断和成像分析.
主要成果:
- 阿普塔默显示出克服神经瘤治疗障碍的潜力.
- 优点包括小尺寸,潜在的血脑屏障透和低免疫性.
- 胺剂适用于新生物标志物发现和向药物输送.
结论:
- 亚胺体现了神经瘤学的有前途的治疗和诊断模式.
- 需要进行进一步的研究,以将基于aptamer的工具推向临床应用.
- 阿普塔默技术具有创新性脑瘤治疗的潜力.
相关概念视频
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
01:22Alzheimer's Disease: Treatment
213
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
213
01:27Tumor Immunotherapy
556
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
556
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K